{"nctId":"NCT01595581","briefTitle":"Testosterone Administration and ACL Reconstruction in Men","startDateStruct":{"date":"2012-04"},"conditions":["Muscle Atrophy","ACL Reconstruction","Trauma","Osteoarthritis"],"count":14,"armGroups":[{"label":"Testosterone","type":"EXPERIMENTAL","interventionNames":["Drug: Testosterone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Testosterone","otherNames":["testosterone enanthate"]},{"name":"Placebo","otherNames":["saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* A complete ACL tear as visualized on MRI\n* The ACL injury can be either \"isolated\" or combined with one or several of the following injuries visualized on MRI and/or arthroscopy:\n* a meniscus tear that is either left untreated or treated with a partial resection\n* a small, stable meniscus tear treated with fixation, but with the fixation not interfering with the rehabilitation protocol\n* cartilage changes verified on MRI with an arthroscopically determined intact surface.\n* A radiographic examination with normal joint status or combined with either one of the following findings:\n* a small-avulsed fragment located laterally, usually described as a Segond fracture, JSN grade 1 or osteophytes grade 1 as determined by the OARSI atlas15\n\nExclusion Criteria:\n\n* Previous major knee injury or knee surgery\n* Associated posterior cruciate ligament (PCL) or medical collateral ligament (MCL) injury grade III\n* Concomitant severe injury to contra-lateral knee\n* Injury to the lateral/posterolateral ligament complex with significantly increased laxity\n* Unstable longitudinal meniscus tear that requires repair and where the following postoperative treatment (we.e. bracing and limited range of motion) interferes with the rehabilitation protocol\n* Bi-compartmental extensive meniscus resections\n* Cartilage injury representing a full thickness loss down to bone\n* Total rupture of MCL/LCL as visualized on MRI.\n* History of deep vein thrombosis (DVT) or a disorder of the coagulative system\n* Claustrophobia\n* Prior or current use of anabolic steroids\n* General systemic disease affecting physical function\n* Chromosomal disorders\n* Medications that interfere with testosterone production or function, including but not limited to 5Î±-reductase inhibitors\n* Any other condition or treatment interfering with the completion of the trial","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Changes in Lean Mass","description":"Relative changes in lean mass from 2 weeks prior to surgery to 6 weeks, 12 weeks, and 24 weeks following surgery between the two groups.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"1.7"},{"groupId":"OG001","value":"-0.1","spread":"1.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.16","spread":"3.48"},{"groupId":"OG001","value":"0.01","spread":"1.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.13","spread":"5.3"},{"groupId":"OG001","value":"1.05","spread":"1.18"}]}]}]},{"type":"SECONDARY","title":"KOOS Scores","description":"Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) from 2 weeks prior to surgery to 6, 12, and 24 weeks post surgery.\n\nKOOS is scored from 0 to 100 with 0 representing extreme knee problems and 100 representing normal knee function.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63.2","spread":"10.6"},{"groupId":"OG001","value":"65.5","spread":"13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.7","spread":"9.9"},{"groupId":"OG001","value":"73.2","spread":"15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":"9.4"},{"groupId":"OG001","value":"86.6","spread":"8.3"}]}]}]},{"type":"SECONDARY","title":"Strength","description":"Changes in muscle strength from the start of rehabilitation to 6, 12, and 24 weeks following surgery between the two groups in the injured limb.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-53.5","spread":"35.8"},{"groupId":"OG001","value":"-33.4","spread":"37.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.3","spread":"52.7"},{"groupId":"OG001","value":"-6.6","spread":"40.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.2","spread":"60.9"},{"groupId":"OG001","value":"19.0","spread":"33.9"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":[]}}}